APA (7th ed.) Citation

Blattmann, P., Farine, H., Dan, B., Stiffler, N., Lefebvre, T., Huynh, C., . . . Strasser, D. S. (2024). Quantification of increased biologically active CXCL12α plasma concentrations after ACKR3 antagonist treatment in humans. CTS: Clinical & Translational Science, 17(2), 1. https://doi.org/10.1111/cts.13708

Chicago Style (17th ed.) Citation

Blattmann, Peter, et al. "Quantification of Increased Biologically Active CXCL12α Plasma Concentrations After ACKR3 Antagonist Treatment in Humans." CTS: Clinical & Translational Science 17, no. 2 (2024): 1. https://doi.org/10.1111/cts.13708.

MLA (9th ed.) Citation

Blattmann, Peter, et al. "Quantification of Increased Biologically Active CXCL12α Plasma Concentrations After ACKR3 Antagonist Treatment in Humans." CTS: Clinical & Translational Science, vol. 17, no. 2, 2024, p. 1, https://doi.org/10.1111/cts.13708.